Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence, Risk Factors at a Tertiary Care Hospital in Nepal: A Cross‐Sectional Study
Shiv Kumar Sah, Ashok Kumar Gupta, Sanjaya Acharya, Suraj Kumar Thakur, Rajkumar Chaudhary, Shiva Pandeya, Arjun Budthapa, Vijaya K C, Sajish Khadgi, Manjita Bajracharya · 2026
Read Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence, Risk Factors at a Tertiary Care Hospital in Nepal: A Cross‐Sectional Study by Shiv Kumar Sah, Ashok Kumar Gupta, Sanjaya Acharya, Suraj Kumar Thakur, Rajkumar Chaudhary, Shiva Pandeya, Arjun Budthapa, Vijaya K C, Sajish Khadgi, Manjita Bajracharya (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13527414.txt.
Description
Shiv Kumar Sah and co-authors measure in 2026 how often nosebleeds strike patients in Nepal who take blood thinning or anti clotting drugs. Nosebleeds are a common side effect of these medicines and can cause real harm. Heart and vessel disease has risen sharply in Nepal, so use of the drugs has spread, while local data on the bleeding risk stayed scarce.
The study ran at a large hospital and counted cases among patients on the two drug classes. It also hunted for the traits that raise the risk, such as age, dose, or other illness. Knowing the local rate tells clinics how much counseling and follow up these patients need. Risk factors can flag who should get preventive nose care.
Catalog record
| CREATOR | Shiv Kumar Sah, Ashok Kumar Gupta, Sanjaya Acharya, Suraj Kumar Thakur, Rajkumar Chaudhary, Shiva Pandeya, Arjun Budthapa, Vijaya K C, Sajish Khadgi, Manjita Bajracharya |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |